What The Delay Of A Promising Muscular Dystrophy Drug Means For Patients, Investors And All Of Biotech

Published: Nov 13, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

In the late 1990s Regeneron, the biotechnology company based in Tarrytown, NY, was developing a treatment for amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig’s disease, which cause paralysis and then death. The company had synthesized a protein missing in people with the disease, and patients reported amazing improvements in symptoms.

Help employers find you! Check out all the jobs and post your resume.

Back to news